Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:3457-3464
Published online before print November 22, 2004, doi: 10.1161/01.CIR.0000148132.15105.0E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/22/3457    most recent
01.CIR.0000148132.15105.0Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jansen, M. A.
Right arrow Articles by Van Echteld, C. J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jansen, M. A.
Right arrow Articles by Van Echteld, C. J.A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
Right arrow Ion channels/membrane transport
Right arrow CT and MRI

(Circulation. 2004;110:3457-3464.)
© 2004 American Heart Association, Inc.


Imaging

Assessment of Myocardial Viability by Intracellular 23Na Magnetic Resonance Imaging

Maurits A. Jansen, PhD; Jan G. Van Emous, PhD; Marcel G.J. Nederhoff, MSc; Cees J.A. Van Echteld, PhD, FESC

From the University Medical Center (M.A.J., J.G.V.E., C.J.A.V.E.), Heart Lung Center Utrecht, NMR Laboratory, and the Interuniversity Cardiology Institute of the Netherlands (M.A.J., J.G.V.E., M.G.J.N.), Utrecht, the Netherlands.

Correspondence to Cees J.A. Van Echteld, PhD, FESC, Heidelberglaan 100, Rm G02.523, PO Box 85500, 3508 GA Utrecht, The Netherlands. E-mail c.j.a.vanechteld{at}hli.azu.nl

Received June 24, 2004; revision received August 19, 2004; accepted August 26, 2004.

Background— Because of rapid changes in myocardial intracellular Na+ (Na+i) during ischemia and reperfusion (R), 23Na magnetic resonance imaging (MRI) appears to be an ideal diagnostic modality for early detection of myocardial ischemia and viability. So far, cardiac 23Na MRI data are limited and mostly concerned with imaging of total Na+. For proper interpretation, imaging of both Na+i and extracellular Na+ is essential. In this study, we tested whether Na+i imaging can be used to assess viability after low-flow (LF) ischemia.

Methods and Results— Isolated rat hearts were subjected to LF (1%, 2%, or 3% of control coronary flow) and R. A shift reagent was used to separate Na+i and extracellular Na+ resonances. Acquisition-weighted 23Na chemical shift imaging (CSI) was alternated with 23Na MR spectroscopy. Already during control perfusion, Na+i could be clearly seen on the images. Na+i image intensity increased with increasing severity of ischemia. During R, Na+i image intensity remained highest in 1% LF hearts. Not only did we find very good correlations between Na+i image intensity at end-R and end-diastolic pressure (R=0.85, P<0.001) and recovery of the rate-pressure product (R=–0.88, P<0.001) at end-R, but most interestingly, also Na+i image intensity at end-LF was well correlated with end-diastolic pressure (R=0.78, P<0.01) and with recovery of the rate-pressure product (R=–0.81, P<0.01) at end-R. Furthermore, Na+i image intensity at end-LF was well correlated with creatine kinase release during R (R=0.79, P<0.05) as well as with infarct size (R=0.77, P<0.05).

Conclusions— These data indicate that 23Na CSI is a promising tool for the assessment of myocardial viability.


Key Words: magnetic resonance imaging • myocardium • ischemia • sodium • reperfusion




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
E.A. Mellon, D.T. Pilkinton, C.M. Clark, M.A. Elliott, W.R. Witschey 2nd, A. Borthakur, and R. Reddy
Sodium MR Imaging Detection of Mild Alzheimer Disease: Preliminary Study
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 978 - 984.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
N. M. Rofsky
Nephrogenic systemic fibrosis: considerations for the cardiologist.
J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 457 - 459.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
L. Belardinelli, J. C. Shryock, and H. Fraser
The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction
Eur. Heart J. Suppl., February 1, 2006; 8(suppl_A): A10 - A13.
[Abstract] [Full Text] [PDF]